Pulmatrix, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Framingham, MA
PULM chart
What traders are saying about $PULM
Latest postsPulmatrix, Inc. news
- Pulmatrix, Inc. (PULM) stock price, news, quote and history
Yahoo Finance Australia ·
- Eos SENOLYTIX’s PTC-2105 Reduced Semaglutide-Associated Lean-Mass Loss in Aged Mice: Data to Be Presented at 19th Sarcopenia, Cachexia & Wasting Disorders International Conference
Yahoo Finance ·
- Pulmatrix (PULM) Stock Price, Chart & Analysis
www.debelegger.nl ·
- Pulmatrix Stock Price Forecast. Should You Buy PULM?
StockInvest.us ·
- Pulmatrix, Inc. (PULM) Seasonal returns chart
Yahoo Finance UK ·
- Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study
Yahoo Finance ·
- Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse
Yahoo Finance ·
- Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria
Yahoo Finance ·
- Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger
Yahoo Finance ·
- Pulmatrix Announces First Quarter 2026 Financial Results
Yahoo Finance ·
- Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger
Yahoo Finance ·
- Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
Yahoo Finance ·
Pulmatrix, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $7.8M | $7.3M | $6.1M |
| Net income | -$5.2M | -$9.6M | -$14.1M | -$18.8M |
| Diluted EPS | $-1.41 | $-2.62 | $-3.87 | $-5.46 |
| Total assets (year end) | $4.1M | $9.9M | $34.0M | $41.0M |
| Cash and equivalents (year end) | $4.1M | $9.5M | $19.2M | $35.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Pulmatrix, Inc.
- Ticker
- PULM (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Framingham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1574235
- Former names
- Ruthigen, Inc.
Frequently asked questions
What exchange is Pulmatrix, Inc. listed on?
Pulmatrix, Inc. trades on the Nasdaq under the ticker symbol PULM.
What industry is Pulmatrix, Inc. in?
Pulmatrix, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Pulmatrix, Inc. headquartered?
Pulmatrix, Inc.'s business address on file with the SEC is in Framingham, MA.
When does Pulmatrix, Inc.'s fiscal year end?
Pulmatrix, Inc.'s fiscal year ends on December 31.
How much revenue did Pulmatrix, Inc. report?
Pulmatrix, Inc. reported $7.8M in revenue for calendar year 2024, according to its SEC filings.